AVITA Medical, Inc.

    Jurisdiction
    United States
    ISIN
    US05380C1027 (RCEL)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. Read full profile

    Fundamentals

    Net revenue
    €50.22M
    Gross margin
    97.6%
    EBIT
    -€46.58M
    EBIT margin
    -92.7%
    Net income
    -€43.33M
    Net margin
    -86.3%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    McNamara Robert N/A +10K $4.50 +$45.00K
    O'Toole David D CFO +2K $4.52 +$9.04K
    McNamara Robert N/A +10K $5.00 +$50.00K
    O'Toole David D CFO +2K $4.81 +$9.62K

    Earnings Calls

    Earnings Calls

    Latest earnings call: August 8, 2025 (Q2 2025)

    Add to watchlist

    Notifications